Conventional and hematopoietic stem-cell-supported (HSC-supported) radioimmunotherapy of relapsed/refractory non-Hodgkin's lymphoma (NHL) with Y-90-humanized LL2 (90-hLL2) anti-CD22 monoclonal antibody (MAb).
JOURNAL OF NUCLEAR MEDICINE（2000）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要